$
1.660
-0.01(-0.599%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
1.740
Open
1.650
VWAP
--
Vol
67.58K
Mkt Cap
445.25M
Low
1.6306
Amount
--
EV/EBITDA(TTM)
--
Total Shares
5.69M
EV
9.43M
EV/OCF(TTM)
--
P/S(TTM)
2.23
Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.
Show More

Valuation Metrics

The current forward P/E ratio for Immuron Ltd (IMRN.O) is -84.80, compared to its 5-year average forward P/E of -13.23. For a more detailed relative valuation and DCF analysis to assess Immuron Ltd 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-13.23
Current PE
-84.80
Overvalued PE
18.16
Undervalued PE
-44.62

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
4.51
Current PS
1.78
Overvalued PS
8.34
Undervalued PS
0.68

Financials

Annual
Quarterly

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

IMRN News & Events

Events Timeline

2025-07-17 (ET)
2025-07-17
06:04:31
Immuron says FY25 global sales exceed projection, up 49% over prior year
select
2025-03-05 (ET)
2025-03-05
06:03:06
Immuron partners with Calmino to distribute ProIBS in Australia, New Zealand
select
2025-01-17 (ET)
2025-01-17
05:09:23
Immuron reports strong sales growth of Travelan
select
Sign Up For More Events

News

9.5
07-18Benzinga
Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
9.5
07-17Newsfilter
Immuron - FY25 global sales exceed projection, up 49% on prior year
7.5
04-11SeekingAlpha
Immuron exceeds AUD$5 million in sales in a fiscal year
Sign Up For More News

FAQ

arrow icon

What is Immuron Ltd (IMRN) stock price today?

The current price of IMRN is 1.66 USD — it has decreased -0.6 % in the last trading day.

arrow icon

What is Immuron Ltd (IMRN)'s business?

arrow icon

What is the price predicton of IMRN Stock?

arrow icon

What is Immuron Ltd (IMRN)'s revenue for the last quarter?

arrow icon

What is Immuron Ltd (IMRN)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Immuron Ltd (IMRN)'s fundamentals?

arrow icon

How many employees does Immuron Ltd (IMRN). have?

arrow icon

What is Immuron Ltd (IMRN) market cap?